ProQR Therapeutics has turned to a new chief financial officer and fresh chief medical officer to support the next phase of growth for the RNA therapies developer. The Netherlands-based ...

Last year, the first phase 3 trial of Sage Therapeutics and Biogen's antidepressant hopeful zuranolone hit its efficacy targets, but raised doubts about the durability of the response. Now ...

Sage Therapeutics has left its view of Biogen's ... last year's $1.1 billion takeover of immunology player HI-Bio – but does not need to rush into a deal. Biogen has been under pressure from ...

The Master of Science in Medical Research (MEDR) program is designed to help talented students develop strong, well-rounded academic portfolios and become competitive candidates for medical school or ...

Melanoma is the most aggressive form of skin cancer. Although less common, it is the most serious due to its high potential for metastasis. Despite the health benefits of sunlight, prolonged ...

Potential treatments need to be subject to the highest standards of safety and efficacy. Transplanting dopamine-releasing neurons into the brain is a promising regenerative therapy for Parkinson ...

A research team at the Institute for Basic Science (IBS) has identified a previously unknown enzyme, SIRT2, that plays a key role in memory loss associated with Alzheimer's disease (AD).

Apr. 16, 2025 — Astronomers have detected the most promising signs yet of a possible biosignature outside the solar system, although they remain ... Sunscreen, Clothes and Caves May Have Helped ...

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. Africa CDC and WHO have updated their joint ...

Apr. 11, 2025 — A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other ...